Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: CASI Pharmaceuticals(CASI) the Revenue is 3.075 M (-60.54%);the EBIT is -10.24 M (-26.7%);the EPS is -0.678 (-23.54%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B60.54%
----
----
EBIT
-0.01B26.70%
----
----
EPS
-0.678123.54%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf